Functional screening in human HSPCs identifies optimized protein-based enhancers of Homology Directed Repair.

Juan A Perez-Bermejo, Oghene Efagene, William M Matern, Jeffrey K Holden, Shaheen Kabir, Glen M Chew, Gaia Andreoletti, Eniola Catton, Craig L Ennis, Angelica Garcia, Trevor L Gerstenberg, Kaisle A Hill, Aayami Jain, Kristina Krassovsky, Cassandra D Lalisan, Daniel Lord, B Joy Quejarro, Jade Sales-Lee, Meet Shah, Brian J Silva, Jason Skowronski, Yuri G Strukov, Joshua Thomas, Michael Veraz, Twaritha Vijay, Kirby A Wallace, Yue Yuan, Jane L Grogan, Beeke Wienert, Premanjali Lahiri, Sebastian Treusch, Daniel P Dever, Vanessa B Soros, James R Partridge, Kristen L Seim
Author Information
  1. Juan A Perez-Bermejo: Graphite Bio, South San Francisco, CA, USA. ORCID
  2. Oghene Efagene: Graphite Bio, South San Francisco, CA, USA.
  3. William M Matern: Graphite Bio, South San Francisco, CA, USA. ORCID
  4. Jeffrey K Holden: Graphite Bio, South San Francisco, CA, USA.
  5. Shaheen Kabir: Graphite Bio, South San Francisco, CA, USA.
  6. Glen M Chew: Graphite Bio, South San Francisco, CA, USA. ORCID
  7. Gaia Andreoletti: Graphite Bio, South San Francisco, CA, USA. ORCID
  8. Eniola Catton: Graphite Bio, South San Francisco, CA, USA.
  9. Craig L Ennis: Graphite Bio, South San Francisco, CA, USA.
  10. Angelica Garcia: Graphite Bio, South San Francisco, CA, USA.
  11. Trevor L Gerstenberg: Graphite Bio, South San Francisco, CA, USA.
  12. Kaisle A Hill: Graphite Bio, South San Francisco, CA, USA.
  13. Aayami Jain: Graphite Bio, South San Francisco, CA, USA.
  14. Kristina Krassovsky: Graphite Bio, South San Francisco, CA, USA.
  15. Cassandra D Lalisan: Graphite Bio, South San Francisco, CA, USA.
  16. Daniel Lord: Graphite Bio, South San Francisco, CA, USA.
  17. B Joy Quejarro: Graphite Bio, South San Francisco, CA, USA.
  18. Jade Sales-Lee: Graphite Bio, South San Francisco, CA, USA.
  19. Meet Shah: Graphite Bio, South San Francisco, CA, USA.
  20. Brian J Silva: Graphite Bio, South San Francisco, CA, USA. ORCID
  21. Jason Skowronski: Graphite Bio, South San Francisco, CA, USA.
  22. Yuri G Strukov: Graphite Bio, South San Francisco, CA, USA.
  23. Joshua Thomas: Graphite Bio, South San Francisco, CA, USA.
  24. Michael Veraz: Graphite Bio, South San Francisco, CA, USA.
  25. Twaritha Vijay: Graphite Bio, South San Francisco, CA, USA.
  26. Kirby A Wallace: Graphite Bio, South San Francisco, CA, USA.
  27. Yue Yuan: Graphite Bio, South San Francisco, CA, USA. ORCID
  28. Jane L Grogan: Graphite Bio, South San Francisco, CA, USA. ORCID
  29. Beeke Wienert: Graphite Bio, South San Francisco, CA, USA.
  30. Premanjali Lahiri: Graphite Bio, South San Francisco, CA, USA.
  31. Sebastian Treusch: Graphite Bio, South San Francisco, CA, USA.
  32. Daniel P Dever: Graphite Bio, South San Francisco, CA, USA.
  33. Vanessa B Soros: Graphite Bio, South San Francisco, CA, USA.
  34. James R Partridge: Graphite Bio, South San Francisco, CA, USA.
  35. Kristen L Seim: Graphite Bio, South San Francisco, CA, USA. scicomms@graphitebio.com. ORCID

Abstract

Homology Directed Repair (HDR) enables precise genome editing, but the implementation of HDR-based therapies is hindered by limited efficiency in comparison to methods that exploit alternative DNA repair routes, such as Non-Homologous End Joining (NHEJ). In this study, we develop a functional, pooled screening platform to identify protein-based reagents that improve HDR in human hematopoietic stem and progenitor cells (HSPCs). We leverage this screening platform to explore sequence diversity at the binding interface of the NHEJ inhibitor i53 and its target, 53BP1, identifying optimized variants that enable new intermolecular bonds and robustly increase HDR. We show that these variants specifically reduce insertion-deletion outcomes without increasing off-target editing, synergize with a DNAPK inhibitor molecule, and can be applied at manufacturing scale to increase the fraction of cells bearing repaired alleles. This screening platform can enable the discovery of future gene editing reagents that improve HDR outcomes.

References

  1. Trends Genet. 2021 Nov;37(11):958-962 [PMID: 34392967]
  2. Mol Ther. 2021 Mar 03;29(3):1057-1069 [PMID: 33160457]
  3. Nat Commun. 2020 Jun 22;11(1):3158 [PMID: 32572033]
  4. Nature. 2020 Feb;578(7794):229-236 [PMID: 32051598]
  5. Sci Transl Med. 2021 Jun 16;13(598): [PMID: 34135108]
  6. Mol Ther Nucleic Acids. 2014 Dec 02;3:e214 [PMID: 25462530]
  7. Mol Cell. 2022 Jan 20;82(2):348-388 [PMID: 35063100]
  8. Nat Biotechnol. 2019 Mar;37(3):224-226 [PMID: 30809026]
  9. Cell Stem Cell. 2017 Nov 2;21(5):574-590 [PMID: 29100011]
  10. Cell Rep. 2019 Jul 23;28(4):1063-1073.e5 [PMID: 31340144]
  11. Nat Rev Genet. 2021 Apr;22(4):216-234 [PMID: 33303992]
  12. Nat Biotechnol. 2023 Apr;41(4):521-531 [PMID: 36008610]
  13. Mol Cancer Ther. 2020 May;19(5):1091-1101 [PMID: 32220971]
  14. Blood. 2017 Jun 22;129(25):3344-3351 [PMID: 28408459]
  15. Nucleic Acids Res. 2021 Jan 25;49(2):969-985 [PMID: 33398341]
  16. Nat Biotechnol. 2018 Jan;36(1):95-102 [PMID: 29176614]
  17. Nucleic Acids Res. 2002 Jan 1;30(1):207-10 [PMID: 11752295]
  18. Front Immunol. 2021 Feb 25;12:648951 [PMID: 33717203]
  19. J Med Chem. 2021 Sep 9;64(17):12723-12737 [PMID: 34428039]
  20. Nat Biotechnol. 2015 Feb;33(2):187-197 [PMID: 25513782]
  21. Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55 [PMID: 15299926]
  22. Nat Med. 2018 Aug;24(8):1216-1224 [PMID: 30082871]
  23. Nat Commun. 2023 Aug 14;14(1):4761 [PMID: 37580318]
  24. Nature. 2016 Nov 17;539(7629):384-389 [PMID: 27820943]
  25. Nat Rev Mol Cell Biol. 2022 Feb;23(2):125-140 [PMID: 34522048]
  26. N Engl J Med. 2019 Mar 7;380(10):947-959 [PMID: 30855744]
  27. Cell Rep. 2020 Sep 1;32(9):108093 [PMID: 32877675]
  28. Nat Cell Biol. 2019 Dec;21(12):1468-1478 [PMID: 31792376]
  29. Nat Med. 2021 Apr;27(4):677-687 [PMID: 33737751]
  30. Cell. 2006 Mar 24;124(6):1283-98 [PMID: 16564017]
  31. Nat Methods. 2017 Jun;14(6):607-614 [PMID: 28459458]
  32. Genome Med. 2015 Aug 27;7:93 [PMID: 26307031]
  33. Front Genet. 2020 Dec 23;11:607428 [PMID: 33424929]
  34. Nat Commun. 2021 Jan 29;12(1):686 [PMID: 33514718]
  35. Mol Biol Cell. 2017 Oct 15;28(21):2854-2874 [PMID: 28814507]
  36. CRISPR J. 2022 Feb;5(1):80-94 [PMID: 35049367]
  37. Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32 [PMID: 15572765]
  38. Nat Commun. 2019 Apr 9;10(1):1634 [PMID: 30967552]
  39. Cell. 2021 Oct 28;184(22):5653-5669.e25 [PMID: 34672952]
  40. Nature. 2015 Feb 12;518(7538):254-7 [PMID: 25642960]
  41. Nat Commun. 2018 Jun 4;9(1):2164 [PMID: 29867139]
  42. Front Genome Ed. 2021 Mar 31;3:618378 [PMID: 34713250]
  43. Cell Stem Cell. 2007 Dec 13;1(6):635-45 [PMID: 18371405]
  44. Cell Stem Cell. 2022 Oct 6;29(10):1428-1444.e9 [PMID: 36206730]
  45. Mol Ther Methods Clin Dev. 2023 Jul 27;30:317-331 [PMID: 37637384]
  46. Nat Rev Mol Cell Biol. 2014 Jan;15(1):7-18 [PMID: 24326623]
  47. Blood. 2021 May 13;137(19):2598-2608 [PMID: 33623984]
  48. Nat Commun. 2024 Jan 2;15(1):111 [PMID: 38169468]
  49. Nat Commun. 2019 Nov 7;10(1):5065 [PMID: 31699977]
  50. Nat Biotechnol. 2023 Aug 3;: [PMID: 37537500]
  51. Nat Commun. 2019 Sep 6;10(1):4045 [PMID: 31492863]
  52. Blood. 2015 Apr 23;125(17):2597-604 [PMID: 25733580]

MeSH Term

Humans
CRISPR-Cas Systems
Recombinational DNA Repair
Gene Editing
DNA Repair
DNA End-Joining Repair

Word Cloud

Created with Highcharts 10.0.0HDRscreeningeditingplatformHomologyDirectedRepairNHEJprotein-basedreagentsimprovehumancellsHSPCsinhibitoroptimizedvariantsenableincreaseoutcomescanenablesprecisegenomeimplementationHDR-basedtherapieshinderedlimitedefficiencycomparisonmethodsexploitalternativeDNArepairroutesNon-HomologousEndJoiningstudydevelopfunctionalpooledidentifyhematopoieticstemprogenitorleverageexploresequencediversitybindinginterfacei53target53BP1identifyingnewintermolecularbondsrobustlyshowspecificallyreduceinsertion-deletionwithoutincreasingoff-targetsynergizeDNAPKmoleculeappliedmanufacturingscalefractionbearingrepairedallelesdiscoveryfuturegeneFunctionalidentifiesenhancers

Similar Articles

Cited By